Inhibitors of tissue transglutaminase

Chen, 1999, Tissue transglutaminase: an enzyme with a split personality, Int. J. Biochem. Cell Biol., 31, 817, 10.1016/S1357-2725(99)00045-X

Nakaoka, 1994, Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function, Science, 264, 1593, 10.1126/science.7911253

Di Venere, 2000, Opposite effects of Ca2+ and GTP binding on tissue transglutaminase tertiary structure, J. Biol. Chem., 275, 3915, 10.1074/jbc.275.6.3915

Folk, 1967, Mechanism of action of guinea pig liver transglutaminase. II. The role of metal in enzyme activation, J. Biol. Chem., 242, 1838, 10.1016/S0021-9258(18)96078-3

Lai, 1998, Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP, J. Biol. Chem., 273, 1776, 10.1074/jbc.273.3.1776

Keillor, 2014, Acyl transfer mechanisms of tissue transglutaminase, Bioorg. Chem., 10.1016/j.bioorg.2014.06.003

Chica, 2004, Tissue transglutaminase acylation: proposed role of conserved active site Tyr and Trp residues revealed by molecular modeling of peptide substrate binding, Protein Sci., 13, 979, 10.1110/ps.03433304

Griffin, 2002, Transglutaminases: Nature's biological glues, Biochem. J., 368, 377, 10.1042/bj20021234

Fesus, 2002, Transglutaminase 2: an enigmatic enzyme with diverse functions, Trends Biochem. Sci., 27, 534, 10.1016/S0968-0004(02)02182-5

Stamnaes, 2010, Redox regulation of transglutaminase 2 Activity, J. Biol. Chem., 285, 25402, 10.1074/jbc.M109.097162

Tucholski, 2001, Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells, Neuroscience, 102, 481, 10.1016/S0306-4522(00)00482-6

Balajthy, 2006, Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions, Blood, 108, 2045, 10.1182/blood-2004-02-007948

Sarang, 2005, Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice, Hepatology, 42, 578, 10.1002/hep.20812

Boroughs, 2014, A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival, J. Biol. Chem., 289, 10115, 10.1074/jbc.M113.464693

Melino, 1994, Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells, Mol. Cell. Biol., 14, 6584, 10.1128/MCB.14.10.6584

Aeschlimann, 1994, Transglutaminases: protein crosslinking enzymes in tissues and body fluids, Thromb. Haemost., 71, 402, 10.1055/s-0038-1642451

Bowness, 1989, Transglutaminase-catalyzed cross-linking: a potential mechanism for the interaction of fibrinogen, low density lipoprotein and arterial type III procollagen, Thromb. Res., 54, 357, 10.1016/0049-3848(89)90094-7

Olsen, 2014, Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules, Am. J. Respir. Cell Mol. Biol., 50, 737, 10.1165/rcmb.2013-0092OC

Olsen, 2011, Transglutaminase 2 and its role in pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 184, 699, 10.1164/rccm.201101-0013OC

Daneshpour, 2011, Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis, J. Drug Target., 19, 624, 10.3109/1061186X.2010.531731

Griffin, 2008, Synthesis of potent water-soluble tissue transglutaminase inhibitors, Bioorg. Med. Chem. Lett., 18, 5559, 10.1016/j.bmcl.2008.09.006

Griffin, M. et al. The Nottingham Trent University, UK. Preparation of peptidyl compounds for use in medicine, 2004-GB25692004113363

Scarpellini, 2014, Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis, J. Am. Soc. Nephrol., 25, 1013, 10.1681/ASN.2013050563

Kumar, 2014, Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways, Int. J. Cancer, 134, 2798, 10.1002/ijc.28623

Kumar, 2014, Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration, BMC Cancer, 14, 256, 10.1186/1471-2407-14-256

Han, 2014, Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor, Eur. J. Cancer, 50, 1685, 10.1016/j.ejca.2014.02.014

Johnson, 1997, Transglutaminase activity is increased in Alzheimer's disease brain, Brain Res., 751, 323, 10.1016/S0006-8993(96)01431-X

Rasmussen, 1994, Identification of glutamine and lysine residues in Alzheimer amyloid βA4 peptide responsible for transglutaminase-catalyzed homopolymerization and crosslinking to α2M receptor, FEBS Lett., 338, 161, 10.1016/0014-5793(94)80356-0

Dudek, 1993, Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of τ, J. Neurochem., 61, 1159, 10.1111/j.1471-4159.1993.tb03636.x

DiFiglia, 1997, Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science, 277, 1990, 10.1126/science.277.5334.1990

MacDonald, 1993, A novel gene containing a trinucleotide repeate that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E

Kahlem, 1996, Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed crosslinking: relevance to diseases of the nervous system, Proc. Natl. Acad. Sci. U.S.A., 93, 14580, 10.1073/pnas.93.25.14580

Lesort, 1998, Distinct nuclear localization and activity of tissue transglutaminase, J. Biol. Chem., 273, 11991, 10.1074/jbc.273.20.11991

Dieterich, 1997, Identification of tissue transglutaminase as the autoantigen of celiac disease, Nat. Med., 3, 797, 10.1038/nm0797-797

Fleckenstein, 2002, Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation reactions, J. Biol. Chem., 277, 34109, 10.1074/jbc.M204521200

Giersiepen, 2012, Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report, J. Pediatr. Gastroenterol. Nutr., 54, 229, 10.1097/MPG.0b013e318216f2e5

Nadalutti, 2014, Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2, Cell. Mol. Life Sci., 71, 1315, 10.1007/s00018-013-1455-5

Caccamo, 2010, Potential of transglutaminase 2 as a therapeutic target, Expert Opin. Ther. Targets, 14, 989, 10.1517/14728222.2010.510134

Folk, 1966, Identification of a functional cysteine essential for the activity of guinea pig liver transglutaminase, J. Biol. Chem., 241, 3238, 10.1016/S0021-9258(18)96522-1

de Macedo, 2000, A direct continuous spectrophotometric assay for transglutaminase activity, Anal. Biochem., 285, 16, 10.1006/abio.2000.4713

Pardin, 2006, Synthesis and evaluation of peptidic irreversible inhibitors of tissue transglutaminase, Bioorg. Med. Chem., 14, 8379, 10.1016/j.bmc.2006.09.011

Castelhano, 1988, Synthesis, chemistry, and absolute configuration of novel transglutaminase inhibitors containing a 3-halo-4,5-dihydroisoxazole, Bioorg. Chem., 16, 335, 10.1016/0045-2068(88)90019-3

Tso, 1980, Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125), J. Biol. Chem., 255, 6734, 10.1016/S0021-9258(18)43633-2

Auger, 1993, Solid-state carbon-13 NMR study of a transglutaminase-inhibitor adduct, Biochemistry, 32, 3930, 10.1021/bi00066a012

Choi, 2005, Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2, Chem. Biol., 12, 469, 10.1016/j.chembiol.2005.02.007

Watts, 2006, Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles, J. Med. Chem., 49, 7493, 10.1021/jm060839a

Yuan, 2007, Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy, Oncogene, 26, 2563, 10.1038/sj.onc.1210048

Siegel, 2007, Transglutaminase 2 inhibitors and their therapeutic role in disease states, Pharmacol. Ther., 115, 232, 10.1016/j.pharmthera.2007.05.003

de Macedo, 2001, Synthesis of dipeptide-bound epoxides and α,β-unsaturated amides as potential irreversible transglutaminase inhibitors, Bioorg. Med. Chem., 10, 355, 10.1016/S0968-0896(01)00292-9

Dafik, 2012, Activation and inhibition of transglutaminase 2 in mice, PLoS ONE, 7, e30642, 10.1371/journal.pone.0030642

Powers, 2002, Irreversible inhibitors of serine, cysteine, and threonine proteases, Chem. Rev., 102, 4639, 10.1021/cr010182v

Hayden, 2003, Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2% suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers, Antimicrob. Agents Chemother., 47, 3907, 10.1128/AAC.47.12.3907-3916.2003

Carmi, 2011, Epidermal growth factor receptor irreversible inhibitors: chemical exploration of the cysteine-trap portion, Mini Rev. Med. Chem., 11, 1019, 10.2174/138955711797247725

Marrano, 2001, Evaluation of novel dipeptide-bound α,β-unsaturated amides and epoxides as irreversible inhibitors of guinea pig liver transglutaminase, Bioorg. Med. Chem., 9, 1923, 10.1016/S0968-0896(01)00101-8

Keillor, 2008, The bioorganic chemistry of transglutaminase: from mechanism to inhibition and engineering, Can. J. Chem., 86, 271, 10.1139/v08-024

Al–Jallad, 2011, Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics, PLoS ONE, 6, e15893, 10.1371/journal.pone.0015893

Colak, 2011, Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation, PLoS ONE, 6, e16665, 10.1371/journal.pone.0016665

Schaertl, 2010, A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors, J. Biomol. Screen., 15, 478, 10.1177/1087057110366035

Prime, 2012, Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease, J. Med. Chem., 55, 1021, 10.1021/jm201310y

Wityak, 2012, SAR Development of lysine-based irreversible inhibitors of transglutaminase 2 for Huntington's disease, ACS Med. Chem. Lett., 3, 1024, 10.1021/ml300241m

Prime, 2012, Irreversible 4-aminopiperidine transglutaminase 2 inhibitors for Huntington's disease, ACS Med. Chem. Lett., 3, 731, 10.1021/ml3001352

Oertel, 2007, A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma, Anal. Biochem., 367, 152, 10.1016/j.ab.2007.05.011

Pliura, 1992, Irreversible inhibition of transglutaminases by sulfonium methylketones: optimization of specificity and potency with ω-aminoacyl spacers, J. Enzyme Inhib., 6, 181, 10.3109/14756369209020168

Badarau, 2013, Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors, Eur. J. Med. Chem., 66, 526, 10.1016/j.ejmech.2013.05.018

Huang, 2009, Transglutaminase inhibition ameliorates experimental diabetic nephropathy, Kidney Int., 76, 383, 10.1038/ki.2009.230

Davies, 1980, Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones, Nature, 283, 162, 10.1038/283162a0

Lorand, 1972, Enzymic coupling of isoniazid to proteins, Biochemistry, 11, 434, 10.1021/bi00753a021

Folk, 1966, Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies, Biochim. Biophys. Acta, 122, 244, 10.1016/0926-6593(66)90066-X

Lorand, 1984, Transglutaminases, Mol. Cell. Biochem., 58, 9, 10.1007/BF00240602

Okauchi, 2009, Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits, Brain Res., 1249, 229, 10.1016/j.brainres.2008.10.035

Connellan, 1969, Mechanism of the inactivation of guinea pig liver transglutaminase by 5,5′-dithiobis-(2-nitrobenzoic acid), J. Biol. Chem., 244, 3173, 10.1016/S0021-9258(18)93110-8

Chung, 1970, Mechanism of the inactivation of guinea pig liver transglutaminase by tetrathionate, J. Biol. Chem., 245, 681, 10.1016/S0021-9258(18)63316-2

Badarau, 2013, Recent advances in the development of tissue transglutaminase (TG2) inhibitors, Amino Acids, 44, 119, 10.1007/s00726-011-1188-4

Gentile, 2004, Transglutaminases: possible drug targets in human diseases, Curr. Drug Targets CNS Neurol. Disord., 3, 99, 10.2174/1568007043482552

Duval, 2005, Structure-activity relationship study of novel tissue transglutaminase inhibitors, Bioorg. Med. Chem. Lett., 15, 1885, 10.1016/j.bmcl.2005.02.005

Case, 2007, Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor, Biochemistry, 46, 1106, 10.1021/bi061787u

Pardin, 2008, Cinnamoyl inhibitors of tissue transglutaminase, J. Org. Chem., 73, 5766, 10.1021/jo8004843

Leblanc, 2001, Kinetic studies of guinea pig liver transglutaminase reveal a general-base-catalyzed deacylation mechanism, Biochemistry, 40, 8335, 10.1021/bi0024097

Pardin, 2008, Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase, Chem. Biol. Drug Des., 72, 189, 10.1111/j.1747-0285.2008.00696.x

Lai, 2008, Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries, Chem. Biol., 15, 969, 10.1016/j.chembiol.2008.07.015

Ozaki, 2010, Potent transglutaminase inhibitors, aryl β-aminoethyl ketones, Bioorg. Med. Chem. Lett., 20, 1141, 10.1016/j.bmcl.2009.12.011

Ozaki, 2011, Potent transglutaminase inhibitors, dithio β-aminoethyl ketones, Bioorg. Med. Chem. Lett., 21, 377, 10.1016/j.bmcl.2010.10.136

Klöck, 2011, Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2, Bioorg. Med. Chem. Lett., 21, 2692, 10.1016/j.bmcl.2010.12.037

Lee, 2001, Potent and selective nonpeptide inhibitors of caspases 3 and 7, J. Med. Chem., 44, 2015, 10.1021/jm0100537

Gillet, 2005, A direct fluorometric assay for tissue transglutaminase, Anal. Biochem., 347, 221, 10.1016/j.ab.2005.09.035

Kim, 2014, Novel 3-arylethynyl-substituted thieno[3,4-b]pyrazine derivatives as human transglutaminase 2 inhibitors, Org. Biomol. Chem., 12, 4932, 10.1039/c4ob00179f

Lee, 2013, Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor, J. Cancer Res. Clin. Oncol., 139, 1279, 10.1007/s00432-013-1433-1

Gong, Y.D. and Kim, S.Y. Dongguk University Industry-Academic Cooperation Foundation, S. Korea. Method for inhibiting transglutaminase 2 activity using 2-alkyloxy-3-phenylethynyl-4a, 5-dihydropyrido[2,3-b]pyrazine derivatives, 2011-1333443220130164813

Ahvazi, 2004, Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium, J. Biol. Chem., 279, 7180, 10.1074/jbc.M312310200

Candi, 2004, Transglutaminase 5 is regulated by guanine-adenine nucleotides, Biochem. J., 381, 313, 10.1042/BJ20031474

Eckert, 2014, Transglutaminase regulation of cell function, Physiol. Rev., 94, 383, 10.1152/physrev.00019.2013

Begg, 2006, Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity, J. Biol. Chem., 281, 12603, 10.1074/jbc.M600146200

Caron, 2012, Using FLIM–FRET to measure conformational changes of transglutaminase type 2 in live cells, PLoS ONE, 7, e44159, 10.1371/journal.pone.0044159

Pavlyukov, 2012, Detection of transglutaminase 2 conformational changes in living cell, Biochem. Biophys. Res. Commun., 421, 773, 10.1016/j.bbrc.2012.04.082

Clouthier, 2012, Real-time monitoring of protein conformational dynamics in solution using kinetic capillary electrophoresis, Angew. Chem. Int. Ed. Engl., 51, 12464, 10.1002/anie.201205575

Pinkas, 2007, Transglutaminase 2 undergoes a large conformational change upon activation, PLoS Biol., 5, 2788, 10.1371/journal.pbio.0050327

Yakubov, 2014, Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction, PLoS ONE, 9, e89285, 10.1371/journal.pone.0089285

Lherbet, 2004, Probing the stereochemistry of the active site of gamma-glutamyl transpeptidase using sulfur derivatives of L-glutamic acid, Org. Biomol. Chem., 2, 238, 10.1039/b310767a

Lherbet, 2004, Synthesis of S-alkyl L-homocysteine analogues of glutathione and their kinetic studies with gamma-glutamyl transpeptidase, Bioorg. Med. Chem. Lett., 14, 3451, 10.1016/j.bmcl.2004.04.072

Pardin, 2009, Photolabeling of tissue transglutaminase reveals the binding mode of potent cinnamoyl inhibitors, Biochemistry, 48, 3346, 10.1021/bi802021c